Quantbot Technologies’s PDL BioPharma, Inc. PDLI Stock Holding History

Quantbot Technologies’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-33,578	Closed	-$72K	–	1750
2019 Q3	$72K	Buy	+33,578	New	+$89.7K	0.01%	906
2015 Q3	–	Sell	-5,876	Closed	-$37K	–	1641
2015 Q2	$37K	Sell	5,876 -4,146	-41%	-$27.8K	0.01%	862
2015 Q1	$70K	Buy	10,022 +2,262	+29%	+$16.4K	0.02%	703
2014 Q4	$59K	Sell	7,760 -36,338	-82%	-$288K	0.02%	796
2014 Q3	$329K	Buy	44,098 +25,000	+131%	+$232K	0.05%	517
2014 Q2	$184K	Buy	+19,098	New	+$170K	0.03%	573

Other funds holding PDLI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

ECM

Engine Capital Management New York $828M AUM 6.49% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Quantbot Technologies's PDLI Position: Q4 2019 in Review

Quantbot Technologies sold out of PDL BioPharma, Inc. (PDLI) in Q4 2019, closing a stake of 33,578 shares — an estimated $72K sold.

Quantbot Technologies first reported a position in PDLI in Q2 2014 and held it in 6 quarters. The position peaked at $329K in Q3 2014. 150 funds tracked by Wall St. Rank hold PDLI as of Q4 2019.

Quantbot Technologies reported no remaining PDL BioPharma, Inc. position as of Q4 2019 after selling out during the quarter.
Quantbot Technologies sold 33,578 PDL BioPharma, Inc. shares in Q4 2019, an estimated $72K.
Quantbot Technologies first reported a position in PDL BioPharma, Inc. in Q2 2014 and held it in 6 quarters.
Quantbot Technologies's PDL BioPharma, Inc. position peaked at $329K in Q3 2014.
150 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q4 2019.

Based on Quantbot Technologies's 13F filing for Q4 2019, filed 10 Feb 2020.